Brolucizumab (also known as RTH258) is a humanized single-chain antibody fragment that inhibits all isoforms of VEGF-A with a molecular weight of 26 kDa. “On a molar basis, 6 mg…
Medical Treatment of PCV Current treatment plans can be formulated based on three pieces of information: the location of the PCV complex, the baseline vision, and the response to previous…
Medscape Ophthalmology Headlines / 2019-07-30 When it comes to the treatment of diabetic macular edema (DME), ophthalmologists have overwhelming evidence to guide their decision-making—but only up to a point. DME…
PDT first requires the intravenous administration of a photosensitizer, followed by the administration of nonthermal red light into the affected eye. After light is absorbed by the photosensitizer, it is…